ADAM10 expression in gastric adenocarcinoma: Results of a curative gastrectomy cohort

Alakus H., Kaya M., ÖZER H., EĞİLMEZ H. R., KARADAYI K.

PAKISTAN JOURNAL OF MEDICAL SCIENCES, cilt.37, sa.2, ss.543-549, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.12669/pjms.37.2.3613
  • Dergi Adı: PAKISTAN JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.543-549
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Objective: Gastric cancer is among the most common human cancers with high mortality rates. ADAM10, a member of the ADAM (a disintegrin and metalloproteinase) family has also been found to be associated with gastric carcinoma and has been suggested as a potential therapeutic target. Here, we investigated the association of ADAM10 expression with prognosis in gastric adenocarcinoma patients that underwent gastric resection with D2 lymph node dissection.